Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've searched for semaglutide weight loss near you, the most useful thing to know is this: as a prescription-only medicine, semaglutide for weight loss is dispensed exclusively through regulated pharmacies following a clinical assessment — which means geography matters far less than it used to. Wegovy, the licensed weight-loss form of semaglutide in the UK, can be prescribed and dispensed through a GPhC-registered online pharmacy that delivers to your door, with no need to travel to a clinic. That said, the decision about whether semaglutide is right for you is a real clinical one, not a box-ticking formality, and a GPhC-registered Independent Prescriber reviews every case before anything is dispensed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The 'near me' instinct makes sense. When you're thinking about a medicine, you want to feel close to the people prescribing it, reassured, not just processed. The practical reality is that semaglutide access in the UK has moved almost entirely away from requiring you to sit in a clinic waiting room. What matters is not the postcode of the pharmacy but whether it's registered with the GPhC. You can check any online pharmacy on the GPhC's public register before you share any personal information with them, take thirty seconds to do it.
The mechanics of regulated online prescribing run roughly like this: you complete a structured health questionnaire, a prescriber reviews it and your clinical details, and if treatment is appropriate they issue a prescription. The medicine is then dispensed by the pharmacy's own registered site and dispatched. At nume, sorry, at the point of dispatch, the pen arrives via tracked DPD delivery in plain, unbranded packaging, so there's nothing to signal to anyone at the door what's inside. That's the legitimate route. It's not a workaround; it's how regulated UK pharmacy works.
Red flags to watch for: anyone offering semaglutide without asking for a clinical consultation, prices dramatically below the market range, or sellers operating through social media with no verifiable GPhC registration. The MHRA has warned repeatedly about counterfeit weight-loss pens, some of which have contained insulin rather than the medicine advertised. If you're searching for semaglutide shots near you, it's worth knowing that an offer looking too good to be true for a prescription medicine is a clear signal to walk away and report it via the MHRA's Yellow Card scheme.
Wegovy's UK licence covers adults with a BMI of 30 or above, or a BMI of 27 to 29.9 alongside at least one weight-related condition, things like hypertension, high cholesterol, obstructive sleep apnoea or prediabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. A prescriber looks at the whole picture, not just a single number; existing conditions, current medications and your history all feed into the assessment.
Worth being clear about: BMI alone doesn't guarantee a prescription. Contraindications exist. People who are pregnant, breastfeeding or trying to conceive are advised not to use semaglutide. It isn't licensed for under-18s. A history of certain conditions (including pancreatitis) means the prescriber will want to discuss things carefully before proceeding. The clinical basis for using semaglutide in weight management is well-established, but 'eligible in principle' and 'suitable for you specifically' are two different conclusions, and only a prescriber can reach the second one.
NICE's guidance on semaglutide for weight loss (TA875) sets conditions for NHS prescribing within specialist services. Private prescribing follows the licensed criteria in the medicine's SmPC, broader access, no waiting list, but with the same clinical rigour applied. NICE's appraisal of semaglutide (TA875) is publicly available if you want to read the evidence base the regulator used.
Since the MHRA approved Wegovy tablets in June 2026, semaglutide for weight loss now comes in two formats. The injection is a once-weekly subcutaneous pen; the tablet is taken once daily, first thing in the morning on an empty stomach, swallowed whole with a small amount of plain water, with at least thirty minutes before eating or drinking anything else. The tablet requires no refrigeration, which makes it genuinely easier to manage for people who travel frequently or simply find the idea of an injection off-putting.
Neither format changes where you need to go to access treatment. Both remain prescription-only, both require the same clinical assessment, and both can be dispensed through a regulated online pharmacy. A fuller picture of how Wegovy works, across both formats, is worth reading before you make a decision on which suits you better, that's a conversation to have with your prescriber, who can factor in your routine, any relevant health history and your preferences.
The 'near me' framing, then, is less about physical distance and more about finding a service that feels personal and responsive. A prescriber who reads your consultation the same day it's submitted, a pharmacy you can verify in thirty seconds, and aftercare available seven days a week, those things close the gap that geography used to fill. If you want to explore how semaglutide compares for weight loss before committing to a consultation, that's a reasonable place to start. When you're ready, starting your free consultation is the natural next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.